[1] KUMARI N, BAGRI K, KUMARI S, et al. Traumatic Brian Injury (TBI) unraveled: molecular disruptions and therapeutic avenues. Inflammopharmacology. 2025;33(8):4323-4334.
[2] MANLEY GT, MAAS AI.Traumatic brain injury: an international knowledge-based approach. Jama. 2013;310(5):473-474.
[3] SPITZ G, HICKS AJ, MCDONALD SJ, et al. Plasma biomarkers in chronic single moderate-severe traumatic brain injury. Brain. 2024;147(11): 3690-3701.
[4] SCHIFF ND, GIACINO JT, BUTSON CR, et al. Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study. Nat Med. 2023;29(12):3162-3174.
[5] ZHONG H, FENG Y, SHEN J, et al. Global Burden of Traumatic Brain Injury in 204 Countries and Territories From 1990 to 2021. Am J Prev Med. 2025; 68(4):754-763.
[6] ZENG Q, YOU G, LI W, et al. By inhibiting pyroptosis to reduce neuroinflammation, PEG-bHb may prevent the development of secondary injury after traumatic brain injury. Exp Neurol. 2025;394:115447.
[7] JACQUENS A, NEEDHAM EJ, ZANIER ER, et al. Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side. Int J Mol Sci. 2022;23(19):11193.
[8] HAN Y, GU J, XU M, et al. Intraoperative application of an antioxidant nanoparticle-hydrogel targeting microglia regulates neuroinflammation in traumatic brain injury. J Nanobiotechnology. 2025;23(1):599-604.
[9] ZOU W, LV Y, LI L, et al. FOXQ1 Regulates Brain Endothelial Mitochondrial Function by Orchestrating Calcium Signaling and Cristae Morphology. Adv Sci (Weinh). 2025;30:e03082.
[10] SOLIMAN E, LEONARD J, BASSO EKG, et al. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury. J Neuroinflammation. 2023;20(1):256.
[11] WANG W, LU G, GUO P, et al. Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous system. Cell Rep Med. 2025;6(9):102319.
[12] BANOEI MM, HUTCHISON J, PANENKA W, et al. Metabolomic in severe traumatic brain injury: exploring primary, secondary injuries, diagnosis, and severity. Crit Care. 2025;29(1):26-37.
[13] LI X. Research Progress on Prognostic Markers of Neuroinflammation in Traumatic Head Injury. Mol Neurobiol. 2025;62(6):7846-7863.
[14] DAS M, MOHAPATRA S, MOHAPATRA SS. New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation. 2012;9:236-242.
[15] LOANE DJ, KUMAR A. Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol. 2016;275:316-327.
[16] PRINZ M, PRILLER J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15(5):300-512.
[17] SHI L, LIU S, CHEN J, et al. Microglial polarization pathways and therapeutic drugs targeting activated microglia in traumatic brain injury. Neural Regen Res. 2026;21(1):39-56.
[18] DELAGE C, TAIB T, MAMMA C, et al. Traumatic Brain Injury: An Age-Dependent View of Post-Traumatic Neuroinflammation and Its Treatment. Pharmaceutics. 2021;13(10):82-93.
[19] FAN Z, JIA M, ZHOU J, et al. Pharmacological targeting cGAS/STING/NF-κB axis by tryptanthrin induces microglia polarization toward M2 phenotype and promotes functional recovery in a mouse model of spinal cord injury. Neural Regen Res. 2025;20(11):3287-3301.
[20] LONG Y, LI XQ, DENG J, et al. Modulating the polarization phenotype of microglia - A valuable strategy for central nervous system diseases. Ageing Res Rev. 2024;93:102160.
[21] SHANG R, LEE S, Senavirathne G, et al. microRNAs in action: biogenesis, function and regulation. Nat Rev Genet. 2023;24(12):816-833.
[22] EL-ASHMAWY NE, KHEDR EG, DARWISH RT, et al. Competing endogenous RNAs network and therapeutic implications: New horizons in disease research. Biochim Biophys Acta Gene Regul Mech. 2025;1868(1):195073.
[23] MA S, LIU M, XU Z, et al. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression. Oncotarget. 2016;7(12):13502-13519.
[24] SABIRZHANOV B, ZHAO Z, STOICA BA, et al. Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins. J Neurosci. 2014;34(30):10055-10071.
[25] SUN Q, WANG B, LI M. MicroRNA-23a-3p targeting of HMGB1 inhibits LPS-induced inflammation in murine macrophages in vitro. Exp Ther Med. 2022;23(5):322-329.
[26] WANG J, HU M, LI L. Clinical Values of miR-23a-3p in Oral Lichen Planus and Its Role in Keratinocyte Proliferation and Inflammatory Response. J Inflamm Res. 2021;14:5013-5021.
[27] DONG C, CHEN M, CAI B, et al. Mesenchymal Stem Cell-Derived Exosomes Improved Cerebral Infarction via Transferring miR-23a-3p to Activate Microglia. Neuromolecular Med. 2022;24(3):290-298.
[28] YANG DD, WAN XD, CHEN AD, et al. Characteristics of traumatic brain injury models: from macroscopic blood flow changes to microscopic mitochondrial changes. Neural Regen Res. 2023;18(10):2268-2277.
[29] SIEBOLD L, OBENAUS A, GOYAL R. Criteria to define mild, moderate, and severe traumatic brain injury in the mouse controlled cortical impact model. Exp Neurol. 2018;310:48-57.
[30] 于永鹏,董霞.RohA信号通路介导miR-133b调控脑缺血再灌注后血脑屏障通透性[J].生物医学,2024,14(3):426-434.
[31] WANG X, QIAN J, LI Y, et al. Protective effects of forsythoside A against severe acute pancreatitis- induced brain injury in mice. Biomed Pharmacother. 2024;178:117301.
[32] SAMAEEKIA R, ADORNO-CRUZ V, BOCKHORN J, et al. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway. Clin Cancer Res. 2017;23(4):1091-1103.
[33] CÁCERES E, OLIVELLA JC, DI NAPOLI M, et al. Immune Response in Traumatic Brain Injury. Curr Neurol Neurosci Rep. 2024;24(12):593-609.
[34] WU H, ZHENG J, XU S, et al.Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation. 2021;18(1):2.
[35] LI N, LU W, TANG L, et al. Microglia in Post-Traumatic Brain Injury (TBI) Cognitive Impairment: From Pathological Changes to Therapeutic Approaches. CNS Neurosci Ther. 2025;31(8):e70568.
[36] ZIGMOND RE, ECHEVARRIA FD. Macrophage biology in the peripheral nervous system after injury. Prog Neurobiol. 2019;173:102-121.
[37] MAVROUDIS I, BALMUS IM, CIOBICA A, et al. The Role of Microglial Exosomes and miR-124-3p in Neuroinflammation and Neuronal Repair after Traumatic Brain Injury. Life (Basel). 2023;13(9):1924.
[38] LUO F, LI X, ZHU Z. Inhibition of neurokinin B promotes functional recovery in traumatic brain injury by increasing M2 microglia. Neuropeptides. 2025;113:102549.
[39] WANG WX, VISAVADIYA NP, PANDYA JD, et al. Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury. Exp Neurol. 2015;265:84-93.
[40] LI Y, SUN M, WANG X, et al. Dental stem cell-derived extracellular vesicles transfer miR-330-5p to treat traumatic brain injury by regulating microglia polarization. Int J Oral Sci. 2022;14(1):44-49.
[41] KISHORE A, PETREK M. Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis. Front Immunol. 2021;12:678457.
[42] ESSANDOH K, LI Y, HUO J, FAN GC. MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response. Shock. 2016;46(2):122-131.
[43] SABIRZHANOV B, MAKAREVICH O, BARRETT J, et al. Down-Regulation of miR-23a-3p Mediates Irradiation-Induced Neuronal Apoptosis. Int J Mol Sci. 2020;21(10):3695.
[44] SHI Z, MAO L, CHEN S, et al. Reversing Persistent PTEN Activation after Traumatic Brain Injury Fuels Long-Term Axonal Regeneration via Akt/mTORC1 Signaling Cascade. Adv Sci (Weinh). 2025;12(6):e2410136.
[45] LI Z, XU R, ZHU X, et al. MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation response in mice. Cell Cycle. 2020;19(1):24-29.
[46] TIANG T, SUN L, ZHU J, et al. MicroRNA-23a-3p promotes macrophage M1 polarization and aggravates lipopolysaccharide-induced acute lung injury by regulating PLK1/STAT1/STAT3 signalling. Int J Exp Pathol. 2022;103(5):198-207.
[47] PAN Y, CENGIZ R, KLUIVER J, et al.Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.Cancers (Basel). 2024;16(6):1126.
[48] KALRA S, MALIK R, SINGH G, et al. Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs. Inflammopharmacology. 2022;30(4):1153-1166.
[49] SMAIL SW, KARIMIAN A, ABDOLMALEKI A, et al. Macrophages’ Functions in the Central and Peripheral Nervous Regeneration. Regen Eng Transl Med. 2024;11(2):312-326.
[50] SHI L, KIDDER K, BIAN Z, et al. SIRPα sequesters SHP-2 to promote IL-4 and IL-13 signaling and the alternative activation of macrophages. Sci Signal. 2021;14(702):eabb3966.
[51] EDIN S, WIKBERG ML, RUTEGÅRD J, et al. Phenotypic skewing of macrophages in vitro by secreted factors from colorectal cancer cells. PLoS One. 2013;8(9):e74982.
[52] TRAVNICKOVA J, NHIM S, ABDELLAOUI N, et al. Macrophage morphological plasticity and migration is Rac signalling and MMP9 dependant. Sci Rep. 2021;11(1):10123.
[53] MCWHORTER FY, DAVIS CT, LIU WF. Physical and mechanical regulation of macrophage phenotype and function. Cell Mol Life Sci. 2015;72(7):1303-1316.
[54] KESSELS S, TRIPPAERS C, MERTENS M, et al. Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits. Sci Adv. 2025;11(35):eadw0128.
[55] 贺琦,王燕.miRNA-23a-3p和TLR4在急性脑出血患者血清中的表达及临床意义[J].海南医学,2023,34(15):2135-2139.
[56] QIN D, WANG C, LI D, et al. Exosomal miR-23a-3p derived from human umbilical cord mesenchymal stem cells promotes remyelination in central nervous system demyelinating diseases by targeting Tbr1/Wnt pathway.J Biol Chem. 2024;300(1):105487.
[57] MAAS AIR, MENON DK, MANLEY GT, et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol. 2022;21(11):1004-1060.
[58] MCDONALD BZ, TARUDJI AW, ZHANG H, et al. Traumatic brain injury heterogeneity affects cell death and autophagy. Exp Brain Res. 2024; 242(7):1645-1658.
[59] SAIDU UF, BULAMA I, ONU A, et al. Experimental animal models in traumatic brain injury research: a comprehensive review of methods and outlook. International Journal of Scientific Reports. 2024;10(6):206-214.
[60] FESHARAKI-ZADEH A, DATTA D. An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms. Front Cell Neurosci. 2024;18:1371213.
[61] ZHANG YP, CAI J, SHIELDS LB, et al. Traumatic brain injury using mouse models. Transl Stroke Res. 2014;5(4):454-471.
[62] YANG X, CHEN L, PU J, et al. Guideline of clinical neurorestorative treatment for brain trauma (2022 China version). Journal of Neurorestoratology. 2022;10(2):100005.
|